🇺🇸 FDA
Patent

US 10085951

Curcuminoid formulations and related methods of treatment

granted A61KA61K31/12A61K9/4858

Quick answer

US patent 10085951 (Curcuminoid formulations and related methods of treatment) held by DESIGNS FOR HEALTH, INC. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DESIGNS FOR HEALTH, INC.
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/12, A61K9/4858